REGENEREX PHARMA, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Regenerex Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2023 to Q3 2024.
  • Regenerex Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $626K, a 30.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $626K -$278K -30.8% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $720K -$220K -23.4% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $756K Mar 31, 2024 10-Q 2024-11-04
Q4 2023 $834K Dec 31, 2023 10-Q 2024-02-05
Q3 2023 $904K Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $940K Jun 30, 2023 10-Q 2023-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.